# Correction: Inclusion of patient-centered, non-microbiological endpoints and biomarkers in tuberculosis drug trials

**Authors:** Andrew R. DiNardo, Wilbert Sabiiti, Stephen H. Gillespie, Sophia B. Georghiou, Norbert Heinrich, Norbert Hittel, Sami Taghlabi, Danna Carrero Longlax, Mikashmi Kohli, Ursula Panzner, Collins Musia, Christoph Lange, Anca Vasiliu, Rob J. W. Arts, Anna M. Mandalakas, Morten Ruhwald, Lieven J. Stuyver, Reinout van Crevel

PMC · DOI: 10.3389/frabi.2025.1748877 · Frontiers in Antibiotics · 2026-03-02

## Full-text entities

- **Diseases:** tuberculosis (MESH:D014376)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12990126/full.md

---
Source: https://tomesphere.com/paper/PMC12990126